Replication and infectivity of hepatitis B virus in HBV-related glomerulonephritis  by Chen, Lizhang et al.
Replication and infectivity of hepatitis B virus in
HBV-related glomerulonephritis
Lizhang Chen a, Chengqiu Wu a, Xuegong Fan b, Jianming Gao a,
Hongling Yin c, Tom Wang d, Jun Wu e, Shi Wu Wen a,f,g,h,*
a School of Public Health, Central South University, Changsha, Hunan, China
bDepartment of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China
cDepartment of Pathology, Xiangya Medical College, Central South University, Changsha, Hunan, China
dCommunity Acquired Infections Division, CIDPC, Public Health Agency of Canada, Ottawa, Ontario, Canada
eBlood Safety Surveillance Division, CIDPC, Public Health Agency of Canada, Ottawa, Ontario, Canada
fThe OMNI Research Group, Department of Obstetrics and Gynecology, University of Ottawa, 501 Smyth Road,
Box 241, Ottawa, Ontario, Canada K1H 8L6
gOttawa Health Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada
hDepartment of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada
Received 31 January 2008; received in revised form 29 July 2008; accepted 6 August 2008
Corresponding Editor: Jane Zuckerman, London, UK











Objective: To examine the presence of hepatitis B surface antigen (HBsAg), hepatitis B core
antigen (HBcAg), and hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in renal
tissues from patients with HBV-related glomerulonephritis.
Methods: Renal tissue biopsies taken from patients with HBV-related glomerulonephritis and two
control groups were prepared for immunocytochemical detection of HBsAg and HBcAg. HBV
cccDNA was examined using a nested PCR.
Results: Of the 63 HBV-related glomerulonephritis patients studied, HBsAg was present in the
renal tissues of 48 (76.2%) and HBcAg in the renal tissues of 27 (42.9%). The HBsAg and HBcAg
positive rates in HBV-related glomerulonephritis patients were higher than those of the 20
patients with non-HBV-related glomerulonephritis ( p < 0.05). However, there was no significant
difference when the HBV-related glomerulonephritis patients were compared with 12 patients
with renal tuberculosis, renal atrophy, renal calculus, and renal tumor with positive serum HBV
markers. In patients with HBV-related glomerulonephritis, there was no significant difference in
HBsAg and HBcAg positive rates in renal tissue between patients with and without serum hepatitis
B e antigen (HBeAg). By nested PCR, two of five patients with HBV-related glomerulonephritis
were positive for HBV cccDNA.
* Corresponding author. Tel.: +1 613 737 8899x73912; fax: +1 613 739 6266.
E-mail address: SWWen@ohri.ca (S.W. Wen).
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Conclusion: The location and replication of HBV in renal tissue make the kidney a potential
reservoir for HBV. HBV cccDNA may be key in the search for anti-HBV drugs.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Hepatitis B infection is common in the Chinese population.
Hepatitis B surface antigen (HBsAg) is found in the serum of
about 10% in China.1 Hepatitis B virus (HBV) infection causes
various disorders, including acute hepatitis, chronic hepati-
tis, cirrhosis, and hepatocellular carcinoma.2,3 HBV infection
can occur in organs outside of the liver and can cause either
pathological hepatic lesions or extrahepatic lesions. Animal
experiments have confirmed that HBV can exist and replicate
in various organs and tissues.4,5 With advances in molecular
techniques, HBV can be detected in patients with HBV infec-
tion outside of the liver, such as in peripheral blood mono-
nuclear cells and tissues or cells of the pancreas, spleen, skin,
and kidney.6,7 It has been shown that HBV may be present in
blood, saliva, semen, vaginal secretions, sweat, breast milk,
tears, and urine.8 Although some studies on infection and
location of HBV in extrahepatic tissues have been carried
out,9 it is still debatable whether HBV can replicate outside
the liver. The results of studies on the location and distribu-
tion of HBV in extrahepatic tissues or cells are not consistent,
and the pathologic lesions caused by extrahepatic infection
with HBV and the pathogenesis of HBV are not fully under-
stood.
HBV covalently closed circular DNA (cccDNA) is a replica-
tive intermediate of HBV DNA, which sustains HBV infection in
humans.10 HBV-related glomerulonephritis is a well-known
extrahepatic syndrome. The objective of this study was to
examine the location and replication of HBV in renal tissues.
Materials and methods
Patients
The study population comprised 63 inpatients with HBV-
related glomerulonephritis (55 males and eight females, with
ages ranging from 15 to 50 years), who had attended the
Renal Clinic of Xiangya Hospital, Central South University,
between April 1995 and April 2003. Twenty non-HBV-related
glomerulonephritis patients (17 males and threes female,
with ages ranging from 17 to 55 years) and 12 patients with
renal tuberculosis, renal atrophy, renal calculus, and renal
tumor, with serum HBV markers (10 males and two females,
with ages ranging from16 to 52 years) were selected at
random as the two control groups. Examination of HBV
cccDNA was carried out in inpatients with HBV-related glo-
merulonephritis recruited between March and April 2003.
The diagnosis of HBV-related glomerulonephritis was based
on established criteria:11 patients with serum and renal tissue
HBV antigens with symptoms and signs of glomerulonephritis
and without other secondary diseases such as lupus nephritis
were diagnosed as HBV-related glomerulonephritis. ELISA was
used to detect serum HBV markers. Renal tissues were pro-
cessed and stained by hematoxylin—eosin staining, periodic
acid—Schiff reaction, periodic acid—methenamine silverstaining method, and Masson staining. Pathologic features of
the renal tissues were examined by light microscopy. HBsAg
and hepatitis B core antigen (HBcAg) in renal tissues were
detected by immunocytochemistry. The reagents used
were purchased from Zhongshan Biological Limited Company,
Beijing, China.
Detection of HBV cccDNA by nested PCR
External and internal primers were designed according to the
genomic X to C region and X to pre-C region of HBV, respec-
tively, both of which spanned the two nicks DR1 and DR2.
Primer sequences were as follows: external primer, upstream
sequence 50-CGACCACGGGGCGCACCTCTC-30; downstream
sequence 50-CGGAAAGAAGTCAGAAGGCAA-30; the length of
PCR product was 462 bp. Internal primer, upstream sequence
50-ACTCCCCGTCGTTGCCTTCTC-30; downstream sequence 50-
AGCTTGGAGGCTTGAACAGTA-30; the length of PCR product
was 335 bp.
Renal tissues were lysed with sodium dodecyl sulfate
(SDS), and DNAwas isolated by phenol and chloroform. Thirty
cycles of DNA amplification were carried out in a total volume
of 30 ml using external primer. The condition of each cycle
was: denaturing at 94 8C for 5 min, then 94 8C for 30 s,
annealing at 55 8C for 30 s, and elongation at 72 8C for
30 s, followed by a final extension of 72 8C for 10 min. A
nested PCR was performed using internal primer. The reac-
tion mixture was cycled in the same conditions. The PCR
products were separated by electrophoresis at 80 V for
50 min in a 2.5% agarose gel, 1 TBE buffer, and stained
with ethidium bromide. The PCR products were visualized in
a UV-transilluminator and the images photographed with a
digital camera to detect the expected 335 bp strap. Renal
tissues from patients with non-HBV-related glomerulonephri-
tis and hepatic tissues from patients with chronic HBV infec-
tion were used as negative and positive controls,
respectively. DNA marker, Taq DNA polymerase, and dNTP
were purchased from the TaKaRa Company, Dalian, China.
The primer was synthesized by Bioasia Company, Shanghai,
China.
All statistical analyses were performed using SPSS version
13.0 (SPSS Inc., Chicago, IL, USA).
Results
All 63 patients with HBV-related glomerulonephritis had
HBsAg in their serum, and 50 of these patients were also
hepatitis B e antigen (HBeAg) positive. Of the 63 patients, 42
(66.7%) had membranous nephropathy and 21 (33.3%) had
mesangioproliferative glomerulonephritis. There was
obvious and irregular thickening of the glomerulus capillaries
in membranous nephropathy, and the diameter of the capil-
laries was decreased; however, thickening in the mesangial
cells, endothelial cells, and epithelial cells was not apparent.
The thickened basal membrane was chain-shaped. Various
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cells, glomerular mesangium, basal membrane, and endothe-
lial cells. In cases of mesangioproliferative glomerulonephri-
tis, moderate thickening was observed in the glomerular
mesangium, but the glomerulus capillaries were normal.
Clusters of immune complex were found deposited in the
glomerular mesangium.
The results of immunocytochemistry indicated that HBsAg
and HBcAg were present in renal tissues, as shown in Figures 1
and 2. The positive rates of HBsAg and HBcAg in renal tissue
were 76.2% (48/63) and 42.9% (27/63), respectively. HBsAg
and HBcAg were predominantly within the kidney cells (glo-
merular mesangium and endothelial cells) and vascular
endothelial cells, depositing linearly or in clusters.
According to the HBV markers in serum, 63 HBV-related
glomerulonephritis patients were categorized into two
groups: patients with and without HBeAg in the serum.
The positive rates of HBsAg and HBcAg in renal tissues of
these two groups showed no significant difference (Table 1).
HBsAg and HBcAg were not detected in the renal tissues of
20 non-HBV-related glomerulonephritis patients (Table 2).
The renal tissue HBsAg and HBcAg expression rates were 75%
(8/12) in the twelve other renal patients with HBV markers
(Table 3).
Of the five HBV-related glomerulonephritis patients
tested, HBV cccDNA was detected in the renal tissues of
two (Figure 3).Figure 1 HBsAg was detected in renal tissue by immuno
Figure 2 HBcAg was detected in renal tissue by immunoDiscussion
HBV is not a virus that is found only in liver cells. Animal
experiments have confirmed that it can exist and replicate in
various other organs and tissues. Wang et al., carrying out
research on HBV perinatal transmission, found that HBV could
be located outside the liver in many organs or tissues in the
fetus.12
Because of the high incidence of HBV infection, HBV-
related glomerulonephritis is a well-known clinical disease
and is an important type of secondary glomerulonephritis in
China.13 Compared with those areas with low HBV infection
rates, such as Western Europe and North America, it is
noticeable that HBV-related glomerulonephritis accounts
for a larger proportion of nephritis in China.
HBsAg and HBcAg immune complexes from the circulation
can be deposited in the glomerular mesangium and endothe-
lial cells, leading to mesangioproliferative glomerulonephri-
tis or other nephritis.14 The results of this study indicate that
both HBsAg and HBcAg are present in the glomerular mesan-
gium and basal membrane in HBV-related glomerulonephri-
tis. We found that the renal tissue HBsAg and HBcAg positive
rates in HBV-related glomerulonephritis are higher than those
in non-HBV-related glomerulonephritis patients, but not
higher than in other renal patients with HBV markers. We
also found no significant difference when comparing the
renal tissue positive rates of HBsAg and HBcAg betweencytochemistry. (A) HBsAg positive; (B) HBsAg negative.
cytochemistry. (A) HBcAg positive; (B) HBcAg negative.
Table 2 Comparison of renal tissue expression of HBV markers between HBV-related glomerulonephritis and non-HBV-related
glomerulonephritis patients.
HBsAg in renal tissuea HBcAg in renal tissueb
Positive Negative Positive Negative
HBV-related glomerulonephritis 48 15 27 36
Non-HBV-related glomerulonephritis 0 20 0 20
HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; HBcAg, hepatitis B core antigen.
a Chi-square = 36.14; p = 0.00.
b Chi-square = 12.7; p = 0.00.
Table 3 Comparison of renal tissue expression of HBV markers between HBV-related glomerulonephritis patients and other renal
patients.
HBsAg in renal tissuea HBcAg in renal tissueb
Positive Negative Positive Negative
HBV-related glomerulonephritis 48 15 27 36
Other renal patients with positive HBV markers 8 4 8 4
HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; HBcAg, hepatitis B core antigen.
a Chi-square = 0.111; p = 0.739.
b Chi-square = 2.30; p = 0.13.
Table 1 HBsAg and HBcAg expression in renal tissues of 63 patients with HBV-related glomerulonephritis.
HBsAg in renal tissuea HBcAg in renal tissueb
Positive Negative Positive Negative
Patients with negative HBeAg 11 2 5 8
Patients with positive HBeAg 37 13 22 28
HBsAg, hepatitis B surface antigen; HBcAg, hepatitis B core antigen; HBeAg, hepatitis B e antigen.
a Chi-square = 0.189; p = 0.663.
b Chi-square = 0.129; p = 0.719.
HBV-related glomerulonephritis 397HBV-related glomerulonephritis patients with and without
serum HBeAg.
HBV is a partially double-stranded DNA virus of the
Hepadnaviridae family. The length of the HBV genome is
3.2 kb.15 There are several types of HBV DNA according to
the stage of replication, such as cccDNA, relaxed circularFigure 3 Detection of HBV cccDNA in renal tissues by nested
PCR. M: DNA marker; lane 1: negative control; lane 2: positive
control; lanes 5 and 7: positive samples.DNA (rcDNA), single-stranded DNA, and integrated DNA. In
the lifecycle of HBV, cccDNA is a template for transcription
of viral pregenomic RNA and all messenger RNA,16 which
play an important role in HBV replication and the establish-
ment of HBV infection.
Because of the existence of several types of HBV DNA at
the different replication stages, it is rather difficult to detect
cccDNA. In this study, HBV cccDNA was examined in renal
tissue biopsies from patients with HBV-related glomerulone-
phritis using a nested PCR. The two sets of primers spanning
the two nicks were well designed so that rcDNA would not be
amplified, but cccDNA would specifically be amplified
because of the two strands.
HBV can cause pathologic changes in the kidney in four
ways.17 First, the HBV antigens in the circulation can be
deposited in the kidney and lead to renal immune lesions.
Second, HBV antigens synthesized in situ due to direct HBV
infection of the kidney can result in immune complex nephro-
pathy or cell immunoreaction nephropathy (cytopathic
effect of HBV). Third, HBV-related glomerulonephritis may
be a kind of renal lesion caused by HBV replication through
various mechanisms. Finally, HBV-related glomerulonephritis
may not be an independent disease but one of the important
extrahepatic manifestations, which results from immune
398 L. Chen et al.failure in the process of HBV infection. The location and
replication of HBV in renal tissue make the kidney a potential
reservoir for HBV. Previous studies have shown that a high
proportion of patients chronically infected with HBV had HBV
DNA detected by PCR in their urine.18,19 As a result, urine
should be considered as a potential route of horizontal and
nosocomial transmission of HBV. Our study also suggests that
the detection of HBV cccDNA in tissues could serve as a useful
tool in the development of anti-HBV drugs, as how to elim-
inate HBV cccDNA is a key point in the search for such drugs.
Acknowledgments
This study was supported by a grant from the Hunan Ministry
of Science and Technology (NO.04SK3044-1), China. We thank
the patients and staff of the participating hospitals in Chang-
sha and Yiyang, China for their support. Dr Wen is a recipient
of the Ontario Women’s Health Council—Institute of Gender
and Health of CIHR Mid Career Award.
Ethical approval: This study was approved by the Research
Ethics Board of the Central South University.
Conflict of interest: No conflict of interest to declare.
References
1. Merican I, Guan R, Amarapuka D, et al. Chronic hepatitis B virus
infection in Asian countries. J Gastroenterol Hepatol 2000;
15:1356—61.
2. Lansang MA. Epidemiology and control of hepatitis B infection: a
perspective from the Philippines. Asia Gut 1996;38(Suppl
2):S43—7.
3. Maupas P, Chiron JP, Barin F, Coursaget P, Goudeau A, Perrin J,
et al. Efficacy of hepatitis B vaccine in prevention of early HBsAg
carrier state in children: controlled trial in an endemic area.
Lancet 1981;1:289—92.
4. Hosoda K, Omata M, Uchiumi K, Imazeki F, Yokosuka O, Ito Y,
et al. Extrahepatic replication of duck hepatitis B virus: more
than expected. Hepatology 1990;11:44—8.5. Chen LB, Chen PL, Wang GL, Song XT, Li YF, Liu CY, et al.
Ultrastructural study on extrahepatic infection of duck hepatitis
B virus in ducks. Chin Med J 1992;105:212—6.
6. Lin CY. Hepatitis B virus deoxyribonucleic acid in kidney cells
probably leading to viral pathogenesis among hepatitis B virus
associated membranous nephropathy patients. Nephron 1993;
63:58—64.
7. Chen LZ, Fan X. Hepatitis B virus infection out of liver and
positioning. J Chin Phys 2004;6:431—2.
8. Boag F. Hepatitis B: heterosexual transmission and vaccination
strategies. Int J STD AIDS 1991;2:318—24.
9. Chen LZ, Fan X, Gao J, et al. Detection of HBsAg, HBcAg, and HBV
DNA in ovarian tissues from patients with HBV infection.World J
Gastroenterol 2005;11:5565—7.
10. Liu LQ, Fu ZP, Zhao ZX. Change in renal pathology of hepatitis B
virus-associated nephritis and non-hepatitis B virus-associated
nephritis. Chin J Lab Diagn 2000;5:161—3.
11. Editorial Committee of the China Journal of Medicine. Abstract
of symposium on HBV related glomerulonephritis. Chin J Med
1990;29:519—21.
12. Wang SS, Peng GF, Jiang PL, et al. Significance and detection of
hepatitis B virus in tissues out of liver by the vertical transmis-
sion. Mod Prev Med 2001;28:267—8.
13. Wang CH, Chen N, Xu ZY, et al. Investigation of correlation
between HBV associated glomerulonephritis and its character-
istics in viral serology. Shanghai Med J 2001;24:674—7.
14. Xiao HJ, Liu JC, Yang JY. Clinicopathologic significance of ‘‘full-
house’’ immunofluorescent staining in glomerular diseases: a 50
cases analysis. Chin J Pediatr 2001;39:151—3.
15. Omata M. Significance of extrahepatic replication of hepatitis B
virus. Hepatology 1990;12:364—6.
16. Werle-Lapostolle B, Bowden S, Locarnini S, et al. Persistence of
cccDNA during the natural history of chronic hepatitis B
and decline during adefovir dipivoxil therapy. 2004;126:
1750—8.
17. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephro-
pathy. Am J Nephrol 2004;24:198—211.
18. Knutsson M, Ljunggren KK. Urine from chronic hepatitis B virus
carriers: implications for infectivity. J Med Virol 2000;60:17—20.
19. Huang LY, Jiang JN. Detection of HBV-DNA in serum, saliva and
urine of 112 patients with hepatitis B by PCR. Guangxi Med J
1997;19:541—3.
